MMR deficiency can be diagnosed through various methods. Immunohistochemistry (IHC) is used to detect the presence or absence of MMR proteins in tumor tissues. Polymerase Chain Reaction (PCR) and next-generation sequencing (NGS) are utilized to assess MSI and identify mutations in MMR genes. These diagnostic tools are essential for identifying patients with Lynch Syndrome and guiding appropriate cancer screening and treatment strategies.
